A new procedure for pseudotumor cerebri

April 22, 2013

A new treatment for pseudotumour cerebri was reported by a team of interventional neuroradiologists and neurosurgeons. Pseudotumour cerebri is a rare condition, which manifests itself by increased pressure in the head, leading to severe headaches, vision impairment and even complete loss of vision and brain damage. It affects more women than men and usually occurs without an obvious trigger, although pregnancy, obesity, and certain medications increase the risk of developing this condition. The diagnosis is made by performing a spinal tap (lumbar puncture) and measuring cerebrospinal fluid pressure. Typical MRI scan findings (narrowing of the ventricles – cerebrospinal fluid filled spaces in the brain) and finding of swollen optic nerves (papilledema)on eye exam confirm this diagnosis.

The new treatment is based on the theory that narrowing of a vein located at the back of the brain is the underlying cause, although this theory remains controversial. Narrowing of this vein is thought to reduce drainage of the cerebrospinal fluid from inside the brain, leading to build up of this fluid and increased pressure inside the skull. The usual treatments for pseudotumor include weight loss, medications that reduce pressure, such as acetazolamide (Diamox), and the surgical placement of a shunt to continuously drain spinal fluid from the brain, thus reducing the pressure.

The study, published in the online edition of the Journal of Neuro-Ophthalmology, shows that lowering pressure inside the vein alleviates the condition and improves vision. The doctors at Johns Hopkins used an advanced ultrasound scanner to thread an expandable metal stent through a vein in the groin, all the way to the transverse sinus, one of the main veins inside the skull draining fluid from the brain.

The study involved only 12 patients, but all of them had immediate relief of their headaches and 10 had lasting improvement. The researchers admitted that the efficacy of this treatment needs to be confirmed in a larger group of patients.


Art credit: JulieMauskop.com

Written by
Alexander Mauskop, MD
Continue reading
June 24, 2026
Fast Walkers Have Better Brain Health into their 80s
Taken together, the super mover data strengthen a simple, clinically useful message: how our oldest patients walk tells us a great deal about how their brains are aging. Fast, confident gait in the ninth decade is not just reassuring from a mobility standpoint; it signals cognitive resilience built on decades of better vascular health, regular physical activity, and supportive environments. For headache and neurology patients, this research offers one more reason to invest in walking, strength, balance, sleep, mood, and lifestyle change: protecting gait speed into late life may be one of the most practical ways to protect thinking and memory as well.
Read article
June 21, 2026
Research
Childhood Stress Rewrites the Body's Metabolism
Two new papers—one in Science and one in Biological Psychiatry—offer a more biologically grounded way to think about the long-term impact of early life stress. Rather than acting only at the psychological level, early adversity appears to leave lasting marks on both the epigenome and mitochondrial function. These findings suggest that early experience may help shape core aspects of cellular energy metabolism, a pathway already central to how we understand migraine.
Read article
June 17, 2026
Research
A New Controlled Trial Suggests Even a Short Behavioral Treatment Can BeEffective for Chronic Pain
A new randomized controlled trial in PAIN found that just six 30-minute CBT sessions for chronic musculoskeletal pain significantly reduced pain interference and improved sleep and physical quality of life, with benefits sustained at follow-up. The findings suggest that brief, scalable behavioral treatments could be integrated into routine primary care and headache practice to improve function without requiring long-term psychotherapy.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe